Establishing Potosi Virus as a Human Pathogen - Part 3
Neurology Minute
In part three of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss practical advice for people receiving anti-CD20 therapy to reduce their exposure to mosquitoes and ticks. Show citation: Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:
info_outline
Establishing Potosi Virus as a Human Pathogen - Part 2
Neurology Minute
In part two of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss the household exposures clinicians should consider when a patient receiving B-cell therapy develops fever, confusion, or new difficulty walking. Show citation: Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:
info_outline
Establishing Potosi Virus as a Human Pathogen - Part 1
Neurology Minute
In part one of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss why a nearly normal spinal fluid profile or a negative antibody test can be misleading when evaluating a patient receiving anti-CD20 therapy for possible encephalitis or another viral infection.
info_outline
Facial Pain Series - Part 2
Neurology Minute
In the second episode of this series, Dr. Derek Stitt discusses Glossopharyngeal neuralgia and nervus intermedius neuralgia, two types of cranial neuralgia.
info_outline
Facial Pain Series - Part 1
Neurology Minute
In part one of this series, Dr. Derek Stitt discusses trigeminal neuralgia and, more specifically, how to make sure that's actually the diagnosis.
info_outline
October 26, 2026 Capitol Hill Report: Conrad 30
Neurology Minute
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN’s efforts to strengthen visa pathways for physicians serving communities across the US. Stay updated with what’s happening on the hill by visiting . Learn how you can get involved with .
info_outline
Youth Football and the Epidemic of Pediatric Brain Injury - Part 2
Neurology Minute
In part two of this series, Dr. Dara Albert and Isaac Thorman discuss guidance for parents weighing whether to let their children play tackle football. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:
info_outline
Youth Football and the Epidemic of Pediatric Brain Injury - Part 1
Neurology Minute
In part one of this series, Dr. Dara Albert and Isaac Thorman discuss football as a major contributor to pediatric traumatic brain injury and its association with subsequent head injuries. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:
info_outline
Acute Optic Neuropathy in Older Adults
Neurology Minute
Dr. Justin Abbatemarco discusses an article that helps us distinguish between the causes of acute optic neuropathy. Show citation: Tisavipat N, Stiebel-Kalish H, Palevski D, et al. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024;11(3):e200214. doi:
info_outline
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis
Neurology Minute
Dr. Aaron Zelikovich discusses how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis. Show citation: Gwathmey KG, Saccà F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi:
info_outlineIn part one of this series, Dr. Jeff Ratliff and Dr. John W. Winkelman discuss clinical lessons from the guidelines with regards to monitoring iron levels and prescribing supplemental iron for patients with restless leg syndrome.
Show references: